tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Neyor, 7 are a BUY (87.5%), 1 are a SELL (12.5%).
Analyst Christopher Neyor works at JPMORGAN with a stock forecast success ratio of 11.11% fulfilled within 79.67 days on average.
Christopher Neyor’s has documented 15 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCRX, Pacira Pharmaceuticals at 07-Mar-2024.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 7/26/2021. The price target of $75 was fulfilled within 239 days with a profit of $16.09 (27.31%) receiving and performance score of 1.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
45
$16.52 (58.01%)
83
1 months 13 days ago
1/3 (33.33%)
$14.36 (46.87%)
239
Buy
57
$28.52 (100.14%)
57
1 months 16 days ago
13/23 (56.52%)
$27.8 (95.21%)
233
Buy
45
$16.52 (58.01%)
45
1 months 19 days ago
2/12 (16.67%)
$16.14 (55.93%)
878
Buy
45
$16.52 (58.01%)
58
1 months 19 days ago
0/5 (0%)
$16.14 (55.93%)
Buy
57
$28.52 (100.14%)
60
2 months 12 days ago
0/2 (0%)
$29.3 (105.78%)
Which stock is Christopher Neyor is most bullish on?
Which stock is Christopher Neyor is most reserved on?
What Year was the first public recommendation made by Christopher Neyor?
